47 260

Cited 0 times in

Role of Bcl-xL in Doxorubicin-Induced Cell Death: Apoptosis and Mitotic Cell Death

Authors
김, 미애
Degree
Master (2005)
Abstract
Bcl-xL overexpressed in various human cancer cells contributes to resistance against various chemotherapeutic agents. In this study, we compared the role of Bcl-xL in high dose (HD) doxorubicin-induced apoptosis and low dose (LD) doxorubicin-induced mitotic cell death. In the first part of this study, we investigated whether anti-apoptotic effect of Bcl-xL on doxorubicin-induced apoptosis was associated with Bcl-xL-mediated modulation of signaling pathways. Bcl-xL overexpression in many cell types effectively blocked HD doxorubicin-induced apoptosis. HD Doxorubicin-induced activation of p38 or JNK was not affected by Bcl-xL overexpression. However, ERK2 was rapidly activated and its high activity was sustained in Bcl-xL-overexpressing cells treated with doxorubicin, whereas its activity was progressively decreased in doxorubicin-treated control cells. CREB, p90RSK, and NF-B, possible target molecules of ERK2, were also activated in Bcl-xL-overexpressing cells treated with doxorubicin. Enhanced expression of wild type ERK2 in control cells alleviated doxorubicin-induced apoptosis. Moreover, forced expression of dominant-negative ERK2 mutant in Bcl-xL overexpressing cells significantly increased the sensitivity to doxorubicin-induced apoptosis, suggesting the critical role of ERK2 in Bcl-xL-mediated blocking of doxorubicin-induced apoptosis. ERK2 activation was not observed in Bcl-2-overexpressing cells treated with doxorubicin, although Bcl-2 overexpression also could inhibit doxorubicin-induced apoptosis. These results suggest that doxorubicin-induced ERK2 activation is specifically mediated by Bcl-xL. Therefore, our results demonstrate that Bcl-xL-mediated ERK2 activation may provide one mechanism by which BcL-xL confers caner cells resistance to doxorubicin-induced apoptosis. In the second part of this study, we investigated whether Bcl-xL overexpression affected senescence and/or mitotic cell death induced by LD of doxorubicin. Bcl-xL overexpression effectively blocked apoptosis induced by high dose HD of doxorubicin, blocking the loss of mitochondrial membrane potential and activation of caspases in Huh-7 cells. In contrast, overexpression of Bcl-xL slightly delayed but not completely blocked doxorubicin-induced senescence-like phenotype (SLP) and the subsequent mitotic cell death. Loss of mitochondrial function and downregulation of mitosis-controlling proteins were also slightly delayed but not abolished by Bcl-xL overexpression. Clonogenicity of hepatoma cells exposed to LD doxorubicin was not enhanced by Bcl-xL overexpression. These results suggest that induction of senescence and/or mitotic cell death by LD doxorubicin may be more effective for Bcl-xL-overexpressing hepatoma cells, which are resistant to the apoptotic effect of chemotherapeutic agents.

Bcl-xL은 많은 종류의 암에 과발현되며 다양한 항암제에 의한 mitochondria의 기능 감소를 막음으로써 항암제 내성을 유발한다. Doxorubicin은 현재 가장 많이 쓰이고 있는 항암제 중 하나이지만, 그 작용 기전이 아직 명확히 규명되지 않고 있다. 본 연구에서는 고농도 doxorubicin에 의해 유도되는 apoptosis와 저농도 doxorubicin에 의해 유도되는 mitotic cell death에서의 Bcl-xL의 기능에 관해 살펴보았다. Bcl-xL이 apoptosis를 막는다는 것은 잘 알려져 있으나, Bcl-xL이 항암제에 반응하여 다른 신호전달체계의 조절을 통해 apoptosis를 막을 수 있음을 보고한 예는 아직까지 없다. 본 연구에서는 Bcl-xL 과발현 세포에 고농도의 doxorubicin을 처리했을 경우 apoptosis가 현저하게 막아졌으며, 이때 MAP kinase 중 ERK2만 활성화되었고 그 downstream 불질인 p90RSK, CREB, NF-B가 활성화되는 것을 확인하였다. Bcl-xL 과발현 세포에서 doxorubicin에 반응하여 활성화되는 ERK2는 doxorubicin에 대한 저항성을 가지게 하는데 중요한 역할을 함을 알 수 있었다. Bcl-2 과발현 또한 doxorubicin에 의한 apoptosis를 막을 수 있으나 ERK2는 활성시키지 못하였다. 다음으로, Bcl-xL의 과발현이 mitotic cell death에 미치는 영향에 대해 조사해보았다. Mitotic cell death 시에는 mitochondria의 기능이 어떻게 변화하는지, 또한 Bcl-xL이 어떤 역할을 하는지 전혀 밝혀져 있지 않은 실정이다. 본 연구를 통해 Bcl-xL 과발현이 저농도 doxorubicin에 의해 유도되는 mitotic cell death를 막지 못한다는 것을 알 수 있었다. Bcl-xL을 과발현시킬 경우 apoptosis 시와는 달리 mitotic cell death 시에 수반되는 mitochondria 기능 감소를 억제하지 못하였다. 따라서, Bcl-xL 과발현으로 인해 apoptosis에 내성을 획득하게 된 암의 치료에 있어서, 저농도 doxorubicin을 이용해 mitotic cell death를 유도하는 것이 효과적인 대안이 될 수 있을 것으로 본다.
Appears in Collections:
Theses > School of Medicine / Graduate School of Medicine > Master
AJOU Authors
김미애
Full Text Link
Files in This Item:
000000000213.PDFDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse